Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 253068
                    [Title] => Rexin-G: Breakthrough in cancer therapy
                    [Summary] => Michael Miller, an American businessman from North Carolina, was diagnosed with 
pancreatic cancer in May 2003. He underwent standard chemotherapy that started in June and continued until January this year. "About October or November last year, I read about Rexin-G and Dr. Erlinda Gordon who developed this product," Miller relates. "Through other family members who were involved with the University of Southern California where Dr. Gordon was  a faculty member, we were able to make some connections." 

                    [DatePublished] => 2004-06-08 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 1432730
                    [AuthorName] => Julie Cabatit-Alegre
                    [SectionName] => Health And Family
                    [SectionUrl] => health-and-family
                    [URL] => 
                )

        )

)

DR. ERLINDA GORDON

Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 253068
                    [Title] => Rexin-G: Breakthrough in cancer therapy
                    [Summary] => Michael Miller, an American businessman from North Carolina, was diagnosed with 
pancreatic cancer in May 2003. He underwent standard chemotherapy that started in June and continued until January this year. "About October or November last year, I read about Rexin-G and Dr. Erlinda Gordon who developed this product," Miller relates. "Through other family members who were involved with the University of Southern California where Dr. Gordon was  a faculty member, we were able to make some connections." 

                    [DatePublished] => 2004-06-08 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 1432730
                    [AuthorName] => Julie Cabatit-Alegre
                    [SectionName] => Health And Family
                    [SectionUrl] => health-and-family
                    [URL] => 
                )

        )

)

abtest

Rexin-G: Breakthrough in cancer therapy

By Julie Cabatit-Alegre | June 8, 2004 - 12:00am

Michael Miller, an American businessman from North Carolina, was diagnosed with pancreatic cancer in May 2003. He underwent standard chemotherapy that started in June and continued until January this year. "About...

Health And Family